Literature DB >> 35049501

Absolute quantitation of individual SARS-CoV-2 RNA molecules provides a new paradigm for infection dynamics and variant differences.

Jeffrey Y Lee1, Peter A C Wing2,3, Dalia S Gala1, Marko Noerenberg1,4, Aino I Järvelin1, Joshua Titlow1, Xiaodong Zhuang2, Natasha Palmalux4, Louisa Iselin1, Mary Kay Thompson1, Richard M Parton1, Maria Prange-Barczynska2,5, Alan Wainman6, Francisco J Salguero7, Tammie Bishop2,5, Daniel Agranoff8, William James6,9, Alfredo Castello1,4, Jane A McKeating2,3, Ilan Davis1.   

Abstract

Despite an unprecedented global research effort on SARS-CoV-2, early replication events remain poorly understood. Given the clinical importance of emergent viral variants with increased transmission, there is an urgent need to understand the early stages of viral replication and transcription. We used single-molecule fluorescence in situ hybridisation (smFISH) to quantify positive sense RNA genomes with 95% detection efficiency, while simultaneously visualising negative sense genomes, subgenomic RNAs, and viral proteins. Our absolute quantification of viral RNAs and replication factories revealed that SARS-CoV-2 genomic RNA is long-lived after entry, suggesting that it avoids degradation by cellular nucleases. Moreover, we observed that SARS-CoV-2 replication is highly variable between cells, with only a small cell population displaying high burden of viral RNA. Unexpectedly, the B.1.1.7 variant, first identified in the UK, exhibits significantly slower replication kinetics than the Victoria strain, suggesting a novel mechanism contributing to its higher transmissibility with important clinical implications.
© 2022, Lee et al.

Entities:  

Keywords:  smFISH; B.1.1.7; COVID-19; SARS-CoV-2; cell biology; early replication; human; infectious disease; microbiology; single-molecule fluorescence in situ hybridisation; variant of concern; viruses

Mesh:

Substances:

Year:  2022        PMID: 35049501      PMCID: PMC8776252          DOI: 10.7554/eLife.74153

Source DB:  PubMed          Journal:  Elife        ISSN: 2050-084X            Impact factor:   8.713


  83 in total

1.  STAR: ultrafast universal RNA-seq aligner.

Authors:  Alexander Dobin; Carrie A Davis; Felix Schlesinger; Jorg Drenkow; Chris Zaleski; Sonali Jha; Philippe Batut; Mark Chaisson; Thomas R Gingeras
Journal:  Bioinformatics       Date:  2012-10-25       Impact factor: 6.937

2.  Single-Molecule Sensitivity RNA FISH Analysis of Influenza Virus Genome Trafficking.

Authors:  Yi-Ying Chou; Timothée Lionnet
Journal:  Methods Mol Biol       Date:  2018

Review 3.  Continuous and Discontinuous RNA Synthesis in Coronaviruses.

Authors:  Isabel Sola; Fernando Almazán; Sonia Zúñiga; Luis Enjuanes
Journal:  Annu Rev Virol       Date:  2015-11       Impact factor: 10.431

Review 4.  Single-molecule approaches to stochastic gene expression.

Authors:  Arjun Raj; Alexander van Oudenaarden
Journal:  Annu Rev Biophys       Date:  2009       Impact factor: 12.981

5.  Molecular detection of SARS-CoV-2 in formalin-fixed, paraffin-embedded specimens.

Authors:  Jun Liu; April M Babka; Brian J Kearney; Sheli R Radoshitzky; Jens H Kuhn; Xiankun Zeng
Journal:  JCI Insight       Date:  2020-06-18

Review 6.  Interferon-stimulated genes and their antiviral effector functions.

Authors:  John W Schoggins; Charles M Rice
Journal:  Curr Opin Virol       Date:  2011-12       Impact factor: 7.090

7.  Development of immunohistochemistry and in situ hybridisation for the detection of SARS-CoV and SARS-CoV-2 in formalin-fixed paraffin-embedded specimens.

Authors:  Fabian Z X Lean; Mart M Lamers; Samuel P Smith; Rebecca Shipley; Debby Schipper; Nigel Temperton; Bart L Haagmans; Ashley C Banyard; Kevin R Bewley; Miles W Carroll; Sharon M Brookes; Ian Brown; Alejandro Nuñez
Journal:  Sci Rep       Date:  2020-12-14       Impact factor: 4.379

8.  Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England.

Authors:  Sam Abbott; Rosanna C Barnard; Christopher I Jarvis; Adam J Kucharski; James D Munday; Carl A B Pearson; Timothy W Russell; Damien C Tully; Alex D Washburne; Tom Wenseleers; Nicholas G Davies; Amy Gimma; William Waites; Kerry L M Wong; Kevin van Zandvoort; Justin D Silverman; Karla Diaz-Ordaz; Ruth Keogh; Rosalind M Eggo; Sebastian Funk; Mark Jit; Katherine E Atkins; W John Edmunds
Journal:  Science       Date:  2021-03-03       Impact factor: 63.714

9.  System-wide Profiling of RNA-Binding Proteins Uncovers Key Regulators of Virus Infection.

Authors:  Manuel Garcia-Moreno; Marko Noerenberg; Shuai Ni; Aino I Järvelin; Esther González-Almela; Caroline E Lenz; Marcel Bach-Pages; Victoria Cox; Rosario Avolio; Thomas Davis; Svenja Hester; Thibault J M Sohier; Bingnan Li; Gregory Heikel; Gracjan Michlewski; Miguel A Sanz; Luis Carrasco; Emiliano P Ricci; Vicent Pelechano; Ilan Davis; Bernd Fischer; Shabaz Mohammed; Alfredo Castello
Journal:  Mol Cell       Date:  2019-02-21       Impact factor: 17.970

View more
  4 in total

1.  SARS-CoV-2 'super-permissive' cells.

Authors:  Ursula Hofer
Journal:  Nat Rev Microbiol       Date:  2022-04       Impact factor: 60.633

2.  Nonproductive exposure of PBMCs to SARS-CoV-2 induces cell-intrinsic innate immune responses.

Authors:  Julia Kazmierski; Kirstin Friedmann; Dylan Postmus; Jackson Emanuel; Cornelius Fischer; Jenny Jansen; Anja Richter; Laure Bosquillon de Jarcy; Christiane Schüler; Madlen Sohn; Sascha Sauer; Christian Drosten; Antoine-Emmanuel Saliba; Leif Erik Sander; Marcel A Müller; Daniela Niemeyer; Christine Goffinet
Journal:  Mol Syst Biol       Date:  2022-08       Impact factor: 13.068

3.  Time-of-Day Variation in SARS-CoV-2 RNA Levels during the Second Wave of COVID-19.

Authors:  Xiaodong Zhuang; Wei Wang; Helene Borrmann; Peter Balfe; Philippa C Matthews; David W Eyre; Elizabeth B Klerman; Jane A McKeating
Journal:  Viruses       Date:  2022-08-05       Impact factor: 5.818

4.  FISHing for COVID-19: Studying SARS-CoV-2 with single-molecule FISH and flow-FISH.

Authors:  Julian J Freen-van Heeren
Journal:  Cytometry A       Date:  2022-09-05       Impact factor: 4.714

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.